Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Mounjaro, a once-weekly injection approved by India's drug regulator, is priced at 4,375 rupees ($50.67) for a 5 mg vial and ...

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the ...

The single-dose vial presentation has marketing authorization from the national drugs regulator—Central Drugs Standard ...

Patients can now purchase a monthly supply of 2.5 mg vials for $348 and 5 mg vials for $499 ... FDA-approved Wegovy in our once-weekly, single-dose pen.” The federal government has authorised a ...

Kourtney Kardashian's ex, Scott Disick, admitted to using Mounjaro on a recent episode of The Kardashians which hit our screens last Thursday (27 February). Here's everything you need to know about ...

The civil servant managed to find 5mg of a weight loss drug at an online ... two low-dose injections of tirzepatide, also known as Mounjaro. She suffered from multiple organ failure, septic ...

The vial doses available are 2.5 milligrams (mg) and 5 mg, which is limited compared to the 6 Zepbound pen doses ... it may cover Mounjaro, which contains the same active ingredient, tirzepatide.